Abstract
Abstract
This study aimed to characterise children and adults diagnosed with influenza who were admitted to three medical centres in northern Israel in the winter of 2015–2016, a unique season due to infection with three types of influenza strains: A/H1N1, A/non-H1N1 and B. Data were collected retrospectively from medical records. Influenza A/H1N1 infected mainly adults (61% vs. 16% in children, P < 0.001) while influenza B was the common type in children (54% vs. 28% in adults, P < 0.001). Adults (36% vs. 5% in children, P < 0.001) and patients infected with A/H1N1 had higher rates of pneumonia (34% vs. 16% and 14% in influenza B and A/non-H1N1, respectively, P = 0.002). Treatment with oseltamivir was prescribed to 90% of patients; adults had higher rates of treatment (96% vs. 84% in children, P = 0.002) as well as patients infected with A/H1N1 (96% vs. 86% in influenza B and A/non-H1N1, respectively, P = 0.04). Oseltamivir was given after a mean of 3.6 days of symptoms. Preferential infection of adults by A/H1N1 was evident in Israel in 2015–2016; pneumonia rates were higher in adults and in A/H1N1-infected patients. Oseltamivir was prescribed to most patients but especially to those infected with A/H1N1, and was given relatively late in the course of the disease.
Publisher
Cambridge University Press (CUP)
Subject
Infectious Diseases,Epidemiology
Reference37 articles.
1. Israel Ministry of Health guidelines. Oseltamivir treatment of hospitalized patients. Available at https://www.health.gov.il/hozer/mr32_2010.pdf (Accessed 17 January 2019).
2. Decreased leukocytes and other characteristics of laboratory findings of influenza virus infections in children;Shen;Journal of Microbiology, Immunology and Infection,2008
3. Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States
4. Cepheid. Xpert flu data sheet. Available at http://www.cepheid.com/en/cepheid-solutions/clinical-ivd-tests/critical-infectious-diseases/xpert-flu (Accessed 1 May 2019).
5. Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014